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We have purified bleomycin hydrolase from yeast (molecular mass 55000 Da). Using protein sequence-derived degenerate 
oligonucleotide primers and amplification by polymerase chain reaction, the yeast gene BLH1 was isolated and characterized. 
The deduced amino acid sequence (483 amino acids) exhibits surprisingly high homology to vertebrate bleomycin hydrolase (43% 
identical residues and 22% conserved exchanges). It contains three blocks of sequences found conserved in other members of the 
thiol proteinase family and thought to be associated with the catalytic entre. BLH1 is non-essential under all growth conditions 
tested. However, in the presence of 3.5 mg bleomycin/ml medium wild-type cells have a slight growth advantage compared to 
blhl mutant cells. 
Bleomycin is a mixture of closely related glycopep- 
tide antibiotics secreted from Streptomyces verticillus 
[1]. It causes radiomimetic DNA damage in bacteria 
and eukaryotes. It also inhibits growth of a number of 
squamous and small cell type tumors in situ and in 
vitro, although its exact mechanism of action is un- 
known. Due to its lack of hepatic, renal and bone 
marrow toxicities, the drug is extensively used in tumor 
therapy [1,2]. A more general use of the drug is, 
however, primarily hampered by two drawbacks, (i) the 
pulmonary toxicity [3] and (ii) the resistance of certain 
cell types and tissues to the drug due to high intra- 
cellular activities of the thiol proteinase bleomycin 
hydrolase [4-6]. The ubiquitous and abundant occur- 
rence of this enzyme in all animal tissues and in 
microorganisms points to an important, although as yet 
unknown function. In order to study bleomycin resis- 
tance, to identify the physiological role of the pro- 
teinase and to understand why certain tumors are 
refractory to therapy by the drug, it may be helpful that 
we have isolated a yeast gene displaying high homology 
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of the encoded protein to bleomycin hydrolase from 
rabbit. 
We have isolated the bleomycin hydrolase protein 
from yeast during a study of a cAMP receptor glyco- 
lipid-anchored to plasma membranes [7]. We have en- 
riched the latter protein by isolating crude plasma 
membranes from yeast spheroplasts by Percoll gradient 
centrifugation and sequential purification of the deter- 
gent-solubilized protein by cAMP-agarose affinity 
chromatograpy, molecular sieving and phenyl Sephar- 
ose lipophilic chromatography which uses the hydro- 
phobicity of the glycolipid anchor-containing protein as 
a parameter for separation. When the eluted proteins 
were separated on a sodium dodecylsulfate polyacryl- 
amide gel, one of the major bands comigrated with the 
authentic, 8-N3-[32p]cAMP photoaffinity-labeled prod- 
uct (apparent molecular mass 54 kDa, as deduced from 
electrophoretic mobility) [7]. This material was excised 
from the gel, eluted and cleaved either with trypsin or 
CNBr. The peptides were separated by high perfor- 
mance liquid chromatography. Two major fragments 
(one from each cleavage) were sequenced (indicated in 
Fig. 2). It turned out from the sequence data (see 
below) that they obviously do not belong to the glyco- 
syl-phosphatidylinositol-anchored cAMP-binding pro- 
tein from yeast plasma membranes. Whether the en- 
riched protein with homology to bleomycin hydrolase 
binds to cAMP agarose and phenyl Sepharose directly 
or interacts with the native cAMP receptor protein 
300 
fortuitously or in a functional complex remains to be 
established in the future. 
The corresponding ene was isolated by using the 
polymerase chain reaction method. Since the intra- 
molecular arrangement of the two eluted and se- 
quenced peptides was unknown, three primers were 
designed from each of them, two overlapping primers 
in the one and a third one in the reverse direction. 
Pairwise amplification by polymerase chain reaction 
and crosswise hybridization led to the identification f 
a DNA fragment, which encoded sequences from both 
protein fragments. The genomic DNA clone, pPMY 
11.0, subsequently isolated from a gene bank con- 
structed from BamHI-digested yeast DNA, contained 
about 11 kbp of genomic DNA and was characterized 
by restriction and hybridization analyses. The region 
cross-hybridizing to the amplified DNA fragment could 
be narrowed down to two HindIII fragments, which 
were sequenced subsequently from the central HindIII 
site in both directions to yield the complete DNA 
sequence of the yeast BLH1 gene (Fig. I A, B). The 
nucleotide sequence analysis and the deduced primary 
structure of the protein are displayed in Fig. 2. The 
open reading frame comprises 483 triplets with a de- 
duced molecular mass of the encoded protein of 55.5 
Da, the calculated isoelectric point is at pH 9.58. 
Structural analyses by using the algorithms of Kyte and 
Doolittle, and Hopp and Woods do not reveal any 
striking structural features and suggest a globular, hy- 
drophilic protein. Southern hybridization with a la- 
beled DNA fragment, derived from the coding region 
of the BLH1 gene shows that BLH1 occurs in single 
copy in the yeast genome (one example is given in Fig. 
1D, lane 1). The codon bias index [8] of 0.35 points to a 
relatively high expression. The DNA sequence flanking 
the gene at its 5' side displays no obvious TATA box. 
However, many yeast genes are known which lack 
obvious TATA sequences. In the putative promoter 
region of BLH1 a perfect consensus equence for an 
abundant DNA binding protein, Grf2p [9], is found, 
immediately followed by a pyrimidine-rich sequence 
(Fig. 2). Grf2p may have a role in nucleosome position- 
ing by excluding nucleosomes from the vicinity of its 
binding site. The same combination of sequence motifs 
as in the BLHl-upstream region also occurs in the 
promoter egion of the yeast profilin gene, PFY1 [10]. 
Deletion of these elements in the PFY1 promoter 
dramatically reduce transcription of PFY1 (H. Herr- 
mann and W. Bandlow, unpublished results). 
Data base searches using the Genetics Computer 
Group (GCG) Sequence Analysis Software Package 
[11] reveal significant sequence similarities to bleomycin 
hydrolase, a cysteine proteinase isolated from rabbit 
lung and liver. A cDNA fragment encoding the central 
portion of this enzyme has been obtained from rabbit 
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Fig. h Inactivation of the BLH1 gene. (A) Genomic restriction map 
of the BLH1 locus. The arrow indicates direction f transcription. 
(B) Restriction map of the sequenced region. Restriction sites rele- 
vant for gene disruption are shown. (C) Genomic organization after 
integration of the linearized plasmid pPMP9-A at the BLH1 locus by 
homologous recombination. Vector sequences between the dupli- 
cated BLHl-coding sequences (indicated by thick bars) are not 
drawn to scale. (D) Genomic Southern blot from wild-type and 
disruption mutants. Genomic DNA was isolated from the haploid 
wild-type strain W303-1A (lane 1), from haploid disruption strains 
(lanes 2 and 3), from heterozygous diploid strains (lanes 4 and 5) and 
restricted with Ndel. The blots were probed with a digoxigenin- 
labeled fragment corresponding to the BLH1 fragment cloned into 
pPMP9-A (indicated by thick bars in (C), C, Clal; E, EcoRI; H, 
HindIlI; N, Ndel. 
rabbit and yeast protein sequences i shown in Fig. 3A. 
Within the region of the known rabbit sequence, the 
homology is highly significant (40 S.D. units, using the 
program ALIGN [12] with the mutation data matrix, 
100 random runs and a penalty for a gap of 20). The 
yeast sequence xtends beyond the known rabbit se- 
quence by 21 amino acids to the N-terminus and 158 
residues to the C-terminus. The overlap of the two 
proteins contains 43% identical amino acids and 22% 
conservative xchanges at comparable positions (Fig. 
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3A). The search for protein motifs and domains reveals 
that a stretch of 17 amino acids (pos. 92-108 of Blhlp) 
is highly homologous to the region containing the cys- 
teine residue conserved in the catalytic centre of eu- 
karyotic thiol proteinases (Fig. 3B). These include cal- 
pain, plant and protozoan cystein proteinases, verte- 
brate lysosomal and secretory cathepsins, and two de- 
velopmentally co-regulated cysteine proteinases from 
the slime mold Dictyostelium discoideum. In addition, 
it can be seen from Fig. 3B that Blhlp from yeast also 
has significant homology to two sequence blocks of 
other cysteine proteinases (which were previously un- 
known from the rabbit enzyme) implied to contribute 
to the active centre, but conserved only in a subset of 
thiol proteinases. 
In order to gain some information about the physio- 
logical role of the protein, we replaced the structural 
BLH1 gene with two different incomplete blhl alleles 
260 GRF2 ............. 
CGTATATTCA GTGCTTTTTG AAATTTAGAA AATAGTCG6~ TTATTGATTA TGCTACATAT GTTATTTTGC TTTAGTATGT GTCAAATAGC ATGCAATCGC CCGGTACTGA GTGACACATC CTTT'~FFCCC 
CTCCCACCAC AAAGTCACCT GCTCTCTTAA TCAATGGGGT TGCATGTGGT AATCAATTGA TAACGCCGGC TGACAAGTCG CCGACGGGCA CCCATAAATA AACGATAAAT AGCCC~'FGCT CTTTTGTTAC 
ATG CTT CCT ACT TCT GTT TCC CGG TCC TTG TAT CTC AAG ACG TTT AGA AGC CAC CTT TTA CGA GCA CCA CAA ATT GTT TTA AAA AGA ATG TCC TCT TCC ATC 
Met Leu Pro Thr Set Val Set Arg Set Leu Tyr Leu Lys Thr Phe Arg Set His Leu Leu Arg Ala Pro Gin lle Val Leu Lys Arg Met Set Ser Ser Ile 
+103 
GAT ATC AGT AAG ATC AAC TCT TGG AAC AAA GAG TTT CAA TCC GAC TTA ACC CAT CAA TTG GCA ACC ACT GTC CTT AAG AAT TAT AAT GCC GAT GAT GCA CTG 
Asp Ile Ser Lys Ile Asn Ser Trp Ash Lys Glu Phe Gin Set Asp Leu Thr His Gln Leu Ala Thr Thr Val Leu Lys Ash Tyr Asn Ala Asp Asp Ala Leu 
~205 
TTC AAC AAG ACT AGA CTG CAA AAG CAA GAT AAC AGG GTT TTC AAC ACT GTT GTC TCT ACT GAT TCC ACT CCA GTC ACC AAC CAA AAA AGC TCT GGT AGA TGT 
Leu Ash Lys Thr Arg Leu Gln LyS Gln Asp Ash Arg Val Phe Ash Thr Val Val Set Thr Asp Set Thr Pro Val Thr Asn Gin Lys Ser Set GIy Arg Cys 
+307 
TGG TTG TTT GCC GCT ACC AAT CAA CTG CGC TTG AAT GTT CTT TCT GAA TTG AAC TTA AAA GAA TTC CAA CTG TCC CAA GCT TAC TTG TTC ~ TAC GAT AAG 
Trp Leu Phe Ala Ala Thr Ash Gln Leu Arg Leu Ash Val Leu Ser Glu Leu Ash Leu Lys Glu Phe Clu Leu Set Gln Ala Tyr Leu Phe Phe Tyr ASp Lys 
+409 
TTG GAA AAG GCC AAC TAT TTC TTG GAC CAA ATC GTC TCC TCG GCT GAT CAA GAC ATC GAC TCA CCT CTC GTG CAA TAC TTG TTA GCA GCT CCA ACA GAA GAC 
Leu Glu Lys Ala Ash Tyr Phe Leu Asp Gln Ile Val Ser Set Ala Asp Gln Asp Ile Asp Ser Arg Leu Val Cln Tyr Leu Leu Ala Ala Pro Thr Glu ASp 
+511 
GGT GGC CAA TAC AGC ATG q~T TTG AAC CTA GTC AAG AAG TAT GGC CTT ATG CCC AAA GAT TTA TAC GGG GAT CTA CCT TAT TCT ACT ACT GCG TCC AGA AAA 
Gly Gly Gln Tyr Ser Met Phe Leu Ash Leu Val Lys Lys Tyr Gly Leu Met Pro Lys Asp Leu Tyr Cly Asp Leu Pro Tyr Ser Thr Thr Ala Set Arg Lys 
+613 
TGC AAT TCT CTG TTG ACT ACT AAA CTG AGA GAA TTT GCC GAG ACT CTA AGA ACA GCT TTG AAA GAG CGT TCT GCC CAT GAT TCC ATA ATT GTC ACT CTG AGA 
Trp Asn Set Leu Leu Thr Thr Lys Leu Arg Glu Phe Ala Glu Thr Leu Arg Thr Ala Leu Lys Glu Arg S~r Ala ASp Ash S~r I le I le Val Thr Leu Arn 
primer I-A 
+715 
GAG CAA ATG CAA AGA GAA ATC TTC AGG TTG ATG TCG TTG TTC ATG GAC ATA CCT CCA GTG CAA CCA AAC GAG CAA TTC ACT TGG GAA TAC GTT GAC AAA GAC 
Glu Gln M~t Gln Arm Clu Ii~ Phe Aro Leu Met get Leu Phe Met Asp Ile Pro Pro Val Gln Pro Asn Glu Gln Phe Thr Trp Glu Tyr Val Asp Lys ASp 
+817 
AAG AAA ATC CAC ACT ATC AAA TCG ACT CCG TTA GAA TTT GCC TCC AAA TAC GCA AAA TTG GAC CCT TCC ACG CCA GTC TCA TTG ATC AAT GAT CCA AGA CAC 
Lys Lys I le His Thr I le Uys Set Thr Pro Leu Glu Phe Ala Ser Lys Tyr Ala Lys Leu Asp Pro Ser Thr Pro Val Set Leu Ile Asn Asp Pro Arg His 
+919 
CCA TAT GGT AAA TTA ATT AAG ATC GAT CGT TTA GGA AAC GTC CTT GGC GGA GAT GCC CTG ATT TAC TTA AAT CTT GAC AAT GAA ACA CTA TCT AAA TTG GTT 
Pro Tyr Gly Lys Leu I le Lys Ile Asp Arg Leu Gly Ash Val Leu Cly Gly Asp Ala Val Ile Tyr Leu Asn Val Asp Asn Clu Thr Leu Set Lya Leu Val 
+1021 W v 
GTT AAG AGA TTA CAA AAT AAC AAA GCT GTC TTT TTT GGA TC~ CAC ACT CCA AAG TTC ATG GAC AAG AAA ACT GGT GTC ATG GAT A~'F GAA TTG TGG AAC TAT 
Val Lys Arg Leu Gln ASh Asn Lys Ala Val Phe Phe Cly Set His Thr Pro Lys Phe Met Asp Lys Lys Thr Gly Val M~t Ash I I~ ~]u Leu TrD ASh "~vr 
primer 2-A primer 2-C / 
CCT GCC ATC GGC TAT AAT ~A CCT CAG CAA AAG GCA TCG CGT ATT AGA TAC CAT GAA AGT TTG ATG ACT CAT GCT ATG ~G ATC ACT GGC TGC CAC GTC GAT 
Pro Ala If@ Glv Tvr Ash Leu Pro C]n Gln Lvs A la  Sat Arg Ile Arg Tyr His GIu Set Leu Met Thr His Ala Met Leu I le Thr Gly CyS His Val Asp 
+1225 
GAA ACG TCT AAA q~FA CCA CTT CGC TAC CGC GTT GAA AAT TCC TGG GGT AAA GAC TCC GGT AAA GAC GGA TTA TAC GTG ATG ACT CAA AAG TAC TTC GAG GAG 
Clu Thr Ser Lys Leu Pro Leu Arg Tyr Arg Val Glu ASh Set Trp GIy Lys Asp Set Gly Lys Asp Gly Leu Tyr Val Met Thr Gln Lys ~r  Phe Glu Glu 
+1327 
TAC TGC TTT CAA ATT GTG GTC GAT ATC AAT GAA TTG CCA AAA GAG CTG GC~ TCA AAA TTC ACC TCA GGT AAG GAA GAG CCG ATT GTC TTG CCC ATC TGG GAC 
Tyr Cys Phe Gln I le Val Val Asp Ile ASh Glu Leu Pro Lys Glu Leu Ala Set Lys Phe Thr Set Gly Ly$ Glu Glu Pro I le Val Leu Pro I le Trp Asp 
+1429 
CCA ATG GGT GCT TTG GCC AAA TAA ATAGTT TCAGCAGCTC TGATGTAGAT ACACGTATCT CGACATGTTT TATTTTTACT ATACATACAT AAAAAGAAAT AAAAAATGAT AACGTGTATA 
Pro Met GIy Ala Leu Ala Lys *** 
Fig. 2. Nucleotide and deduced amino acid sequences of BLH1. The putative Orf2p-binding site is overlined, the adjacent pyrimidine-rich region 
is indicated by dots. The two peptides sequenced from the purified protein are underlined. The DNA regions corresponding to the primers 
effective in PCR amplification are overlined by arrows. The sequences of these degenerate oligonucleotides were: 5' CAA/GATGCAA/GC/ 
AGI /CGAA/GAT (I-A); 5' CCIATI/CGCI/CGGA/GTAA/GTT (2-A); 5' TGT/CTGI/CGGI/CAA/GA/GTTA/GTA (2-C). I denotes 
inosine. 
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as detailed in Fig. 1C. For this purpose the coding 
sequence contained between the ClaI site at pos. + 100 
and the EcoRI site at pos. +615 was cloned into the 
yeast integration vector pRS306 harbouring the URA3 
gene as a selective marker [13] to yield clone pPMP9-A. 
After cleavage of pPMP9-A with HindlII (pos. +383 
of the coding region of BLH1) the resulting linear 
plasmid DNA was transformed into either haploid or 
diploid yeast wild-type ceils. The correct integration of 
the plasmid by homologous recombination at the BLH1 
locus leads to the duplication of those BLH1 DNA 
sequences cloned into pRS306, the resulting two in- 
complete copies being separated by sequences from the 
vector (Fig. 1C). The integration event was proven by 
Southern blotting of genomic DNA restricted with 
NdeI. The blot was probed with the BLHl-derived 
sequences cloned into pPMP9-A. DNA from wild-type 
cells yields a single signal corresponding to 1.1 kbp 
(Fig. ID, lanes 1), whereas the haploid disruption 
mutants display two signals as expected, corresponding 
to 2.5 and 3.5 kbp (Fig. 1D, lanes 2 and 3) instead of 
the 1.1 kbp band (cf. Fig. 1B and C). Heterozygous 
diploids contain both, the wild-type and the disrupted 
alleles. Consequently, all three signals can be seen with 
DNA from heterozygous diploid disruption strains (Fig. 
1D, lanes 4 and 5). 
blhl disruption mutants were found to be viable in 
the haploid state. When the growth behaviour of the 
haploid mutant and the isogenic wild-type strains was 
compared, no differences were observed on glucose, 
galactose and glycerol media. Also long-term experi- 
ments, where cells were shifted from one carbon source 
to another (eight changes of media), revealed no disad- 
vantage for the blhl mutant strains compared to wild- 
type cells. In addition, heterozygous diploids sporulate 
well, and the spores germinate. It must be concluded 
from these results that the gene is dispensable for 
vegetative and meiotic growth, cell viability and differ- 
entiation. Finally, the haploid wild-type strain (with a 
functional BLH1 allele) was compared to the disrup- 
tion strain with respect o growth in the presence of 
bleomycin. For this purpose co-cultivation experiments 
of the haploid strain W303-1A and of the isogenic 
blhl mutant strain were performed: cells of both strains 
pre-grown overnight in the presence of bleomycin were 
mixed and incubated for 2 days in the absence of 3.5 
mg bleomycin/ml medium (which leads to about 50% 
growth inhibition). The ratio of the wild-type and mu- 
tant cells was monitored by replica-plating at the be- 
ginning of the experiment and after two days of growth 
by testing uracil auxotrophy (URA3 has been used as 
the selective marker to inactivate BLH1). The initial 
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Fig. 3. Comparison of the deduced amino acid sequence of BLH1 to other cysteine proteinases: (A) residues identical to the known sequence of 
rabbit bleomycin hydrolase [6] at corresponding positions are shaded. (B) Alignment of Blhlp with other cysteine proteinases in the regions 
containing the putative active-site cysteine, histidine and asparagine (indicated by stars) [14]. Amino acids identical to Blhlp are shaded. 
Sequences were taken from [6,14-19]. 
ratio of 55% blhl mutant and 45% wild-type cells 
changed after two days (i.e., 26 generations) to 27% 
mutant and 73% wild-type cells, indicating a slightly 
higher sensitivity of the mutant cells to the drug. In 
contrast, the ratios of both types of ceils did not change 
significantly in the absence of bleomycin (55%/45% 
versus 56%/44% blhl/BLH1 cells). These results 
make it likely that BLH1, in fact, encodes a cysteine 
proteinase capable of hydrolyzing bleomycin. The lack 
of a detectable phenotype in blhl mutant cells in the 
absence of bleomycin as well as the only slightly in- 
creased sensitivity to bleomycin suggest hat yeast may 
contain other proteinases with overlapping substrate 
specificities in addition to bleomycin hydrolase. 
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